Pharmacokinetics of Sedatives and Analgesics During Extracorporeal Membrane Oxygenation (ECMO) Support

ConditionDrug Effect

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age0-17

SponsorBoston Children's Hospital

About this trial

This study will measure plasma concentrations of dexmedetomidine, fentanyl, morphine and midazolam in pediatric patients supported with extracorporeal membrane oxygenation (ECMO) aiming to understand the pharmacokinetics of these drugs in this setting.

Eligibility criteria

Qualifiers

supported on ECMO

receiving one or a combination of the following drugs dexmedetomidine, fentanyl, midazolam or morphine as part of sedation management

Disqualifiers

None

Trial design

Treatments tested in this trial

Dexmedetomidine
Fentanyl
Midazolam
Morphine

Treatment groups

20 Participants

are divided into 1 treatment group

Sponsors and collaborators

Boston Children's Hospital

Lead sponsor

Source ClinicalTrials.gov